S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:INTI

Inhibitor Therapeutics (INTI) Stock Price, News & Analysis

$0.07
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$0.07
$0.07
50-Day Range
$0.05
$0.10
52-Week Range
$0.01
$0.30
Volume
47,016 shs
Average Volume
16,545 shs
Market Capitalization
$12.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
INTI stock logo

About Inhibitor Therapeutics Stock (OTCMKTS:INTI)

Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States. The company engages in the development of therapies for prostate and lung cancer utilizing SUBA-Itraconazole, an oral formulation of the drug itraconazole; and conducted a positive Phase 2b study of SUBA-Itraconazole for the treatment of basal cell carcinoma nevus syndrome. The company was formerly known as HedgePath Pharmaceuticals, Inc. and changed its name to Inhibitor Therapeutics, Inc. in August 2019. Inhibitor Therapeutics, Inc. was founded in 1992 and is based in Tampa, Florida.

INTI Stock Price History

INTI Stock News Headlines

Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Inhibitor Therapeutics Inc.
PAA Scale Inhibitor Market Top Players By 2031
Inhibitor Therapeutics, Inc. (INTI)
See More Headlines
Receive INTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:INTI
Employees
3
Year Founded
N/A

Profitability

Net Income
$12.11 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.07 per share
Book Value
$0.05 per share

Miscellaneous

Free Float
164,057,000
Market Cap
$12.04 million
Optionable
Not Optionable
Beta
-0.81
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Francis E. O'Donnell Jr. (Age 74)
    M.D., Founder, Executive Chairman & CEO
    Comp: $600k
  • Mr. James A. McNulty CPA (Age 74)
    Interim CFO, Treasurer & Secretary
    Comp: $205.4k

INTI Stock Analysis - Frequently Asked Questions

How have INTI shares performed in 2024?

Inhibitor Therapeutics' stock was trading at $0.0920 at the beginning of 2024. Since then, INTI stock has decreased by 23.9% and is now trading at $0.07.
View the best growth stocks for 2024 here
.

Are investors shorting Inhibitor Therapeutics?

Inhibitor Therapeutics saw a decrease in short interest in March. As of March 15th, there was short interest totaling 100 shares, a decrease of 99.6% from the February 29th total of 24,800 shares. Based on an average daily volume of 10,800 shares, the days-to-cover ratio is currently 0.0 days.
View Inhibitor Therapeutics' Short Interest
.

When is Inhibitor Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our INTI earnings forecast
.

How do I buy shares of Inhibitor Therapeutics?

Shares of INTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:INTI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners